Bevacizumab is an antibiotic that is used to treat certain cancers. Thanks to the development of science and technology, vascular antibiotic therapy with Bevacizumab helps increase the survival time of patients up to 18 - 20 months.

Recurrence of cancer is a condition in which cancer cells recur again after a patient has finished treatment, and the tumor is no longer detected in the body for a while.

After successful treatment, cancer can still come back after a while in that organ or surrounding areas or metastasize to another organ in the body.

Curing cancer recurrence requires patients to be patient and follow the doctor's instructions. Treatments for recurrent cancer depend on the type of cancer and how far the malignant cells have spread.